Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
BSX > SEC Filings for BSX > Form 8-K on 3-Mar-2014All Recent SEC Filings

Show all filings for BOSTON SCIENTIFIC CORP



Change in Directors or Principal Officers, Financial Statements and Exhibi

Item 5.02 Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d) Election of Directors

On February 25, 2014, the Board of Directors (the "Board") of Boston Scientific Corporation (the "Company"), upon the recommendation of the Nominating and Governance Committee, increased the number of directors comprising the Board from eleven to twelve and appointed Edward J. Ludwig as a director of the Company, filling the vacancy, to hold office until the next annual meeting of stockholders, in each case, effective March 1, 2014.

Under the Company's non-employee director compensation program (the "Program"), Mr. Ludwig will receive standard non-employee director compensation, prorated for the time period from the effective date of Mr. Ludwig's appointment to the date of the Company's 2014 annual meeting of stockholders, which includes (i) a cash retainer of $13,562 (representing the prorated amount of the Program's annual cash retainer of $75,000) and (ii) a restricted stock grant valued at $31,644 (representing the prorated amount of the Program's annual grant of restricted stock having a value of $175,000) vesting at the end of his term. The actual number of shares of restricted stock to be granted to Mr. Ludwig will be determined by dividing $31,644 by the closing price of the Company's common stock on the date of grant, April 1, 2014, which is the first business day of the month following the month in which he was appointed.

In connection with Mr. Ludwig's appointment to the Board, the Company intends to enter into an indemnification agreement with Mr. Ludwig in substantially the same form as the Company has entered into with each of the Company's existing directors and as previously filed with the Securities and Exchange Commission.

A copy of our press release announcing Mr. Ludwig's appointment is filed herewith as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

99.1 Press Release issued by Boston Scientific Corporation dated March 3, 2014.

  Add BSX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for BSX - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.